Skip to content

A multicenter, randomized controlled trial investigating the clinical efficacy and safety of acupuncture treatment for sarcopenia in the elderly

A multicenter, randomized controlled trial investigating the clinical efficacy and safety of acupuncture treatment for sarcopenia in the elderly

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000374
Enrollment
Unknown
Registered
2024-09-04
Start date
2024-10-09
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sarcopenia

Interventions

Acupuncture Group:Acupuncture with Resistance training
Sham acupuncture group:Sham acupuncture with Resistance training

Sponsors

Affiliated Hospital of Shaanxi University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1 patients who meet the diagnostic criteria of sarcoidosis; 2 patients who were 60-80 years old and of either sex; 3 patients who agreed to participate in the study and signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1. A severe primary disease of the vital organs (such as the heart, kidneys, liver, etc.) or of the vital system. 2. People who have physical problems in their limbs (such as fractures, cerebral infarction, or intracerebral hemorrhage) or who have weight-related problems (such as long-term steroid use) . 3. The ADL score was less than 60 in those whose ADL was limited to some extent. 4. Implants of electronic devices or metal objects (such as artificial pacemaker or artificial joints) 5. Severe mental illness or cognitive impairment 6. Have underlying diseases (hypertension, diabetes, coronary heart disease, etc.) and the underlying diseases are not in a stable stage; 7. Patients with reduced muscle mass or strength due to other causes (myasthenia gravis, spinal cord injury, diabetes, COPD, etc.) were excluded. 8. Long-term bedridden patients caused by sequelae of stroke, spinal cord injury and limb disability were excluded. 9. Patients with other muscular diseases such as amyotrophic lateral sclerosis and muscular dystrophy were excluded.

Design outcomes

Primary

MeasureTime frame
Appendicular skeletal muscle mass,ASMI;

Secondary

MeasureTime frame
Irisin;6m pace test;L3 level abdominal muscle density;Myostatin;Waist circumference;Calf circumference;Hip circumference;five times sit to stand test,FTSST;Short physical performance battery,SPPB;Muscle grip strength of upper limbs;

Countries

Chinese

Contacts

Public ContactWenxiong Li

Shaanxi University of Chinese Medicine

liwenxiong55@163.com15706016769

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026